Posts tagged Juno Therapeutics Inc


Company Update (NASDAQ:JUNO): Juno Therapeutics Inc Opens New Headquarters and Research Center

Juno Therapeutics Inc (NASDAQ:JUNO) unveiled its new headquarters and research facility, located in the heart …

Read more

Juno Therapeutics Inc (JUNO) Looks Well Positioned in Light of KITE Takeout: Top Analyst

David Nierengarten Re-evaluates JUNO; Upgrades Shares to Outperform

Read more

Biotech World’s Big M&A Frenzy: Kite Pharma Inc (KITE), Gilead Sciences, Inc. (GILD), Juno Therapeutics Inc (JUNO)

How Has a Deal Between Kite and Gilead Likewise Sent Juno Shares Jumping?

Read more

BTIG Shares Two Cents on Juno Therapeutics Inc (JUNO) Following ASCO Abstract

In a research report published Monday, BTIG analyst Dane Leone reiterated a Neutral rating on …

Read more

Juno Therapeutics Inc (JUNO) Presents Updated TRANSCEND NHL 001 Trial Data at ASCO

Juno Therapeutics Inc (NASDAQ:JUNO) announced updated data from the TRANSCEND trial of JCAR017 in relapsed …

Read more

J.P. Morgan Clips Price Target on Juno Therapeutics Inc (JUNO) Following Termination of JCAR015 Program

Juno Therapeutics Inc (NASDAQ:JUNO) shares are dropping 7% following the biotech firm’s official termination of …

Read more

Juno Therapeutics Inc (JUNO) Announces Fourth Quarter and 2016 Results

Juno Therapeutics Inc (NASDAQ:JUNO) reported financial results and business highlights for the fourth quarter and …

Read more

Biotech Insights: Alcobra Ltd (ADHD), Biogen Inc (BIIB), Juno Therapeutics Inc (JUNO)

Alcobra Ltd  Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the …

Read more

J.P. Morgan Provides Takeaways On Juno Therapeutics Inc (JUNO) Following Healthcare Conference

J.P. Morgan analyst Cory Kasimov is out today sharing insights from the sidelines on Juno …

Read more

Stock Update (NASDAQ:JUNO): Juno Therapeutics Inc and Celgene Corporation’s Investigational Drug JCAR017 Granted Breakthrough Therapy Designation from FDA and Priority Medicines Eligibility from EMA

Juno Therapeutics Inc (NASDAQ:JUNO) and Celgene Corporation (NASDAQ:CELG) announced that the U.S. Food and Drug …

Read more